SlideShare a Scribd company logo
Israel: Modelo de innovación biomédica
Ariel Roguin MD PhD
Head, Interventional Cardiology
Rambam Medical Center,
B. Rappaport - Faculty of Medicine
Technion - Israel Institute of Technology
Haifa 31096 ISRAEL Mobile
aroguin@technion.ac.il
Flash memory
WAZE navigation
Google 2013: 1,200,000 Million US$
Israel: Modelo de innovación biomédica
 El modelo Israelí,
 Como se trabaja allí
 Como se ha llegado a conseguir ese nivel
de superespecialización en innovación,
 La relación de los médicos con la gestión
de i+I+D [investigacion, desarrollo e
innovacion tecnologica]
5
Israel Facts and Figures
Israel
HAIFA
Established 1948
Area: 22,072 km2
ES:504,645 km2 [X23]
Density: 387/km2
ES: 92/km2 [X4]
Population ~8 millions
ES: ~48 millions [X6]
Unemployment: 6%
ES: ~25% [X4]
GDP per capita 38,000 US$
ES: 33,000 US$
GDP growth 3.3%
ES: 2%
Natural resources. 0
Security challenges ++++
Isolated from its neighbors
Most desert
450KM
60-70KM
90KM
50KM
40KM
45KM
• No. 1 in patent / capital
• 750 life science companies
• 7.1 million people = Silicon Valley
• 20 x less investment money
• Second generation entrepreneurs
• Tenacious spirit, focus, and chaos
Israel and Innovations in Life Science
Major Israeli Medical Innovations
 Teva Industry
• Copaxon, Azilect
 Stents
• InStent, BeStent, Nir, Express,
InspireMD and more
 Biosense
• Revolutionized EP
 Given Imaging
• Revolutionized GI diagnosis
 Ventor
• Novel Transapical Medtronic Valve
Haifa
Yokneam
Major Israeli Medical Innovations
Multislice CT angiographay [Elscint, Picker, Marconi, Philips]
MRI imaging [GE R&D] [investigacion, desarrollo]
Echocardiography 3D and strain [GE ultasound]
Hybrid CT/SPECT [GE Nuclear]
Israel: Modelo de innovación biomédica
 El modelo Israelí,
 Como se trabaja allí
 Como se ha llegado a conseguir ese nivel
de superespecialización en innovación,
 La relación de los médicos con la gestión
de i+I+D [investigacion, desarrollo e
innovacion tecnologica]
Health System in Israel
• Medical insurance plan is obligatory.
• All entitled to basic health care as a fundamental right.
• In a survey of 48 countries in 2013, Israel's health system was ranked
fourth in the world in terms of efficiency.
Health System in Israel
• Medical insurance plan is obligatory.
• All entitled to basic health care as a fundamental right.
• In a survey of 48 countries in 2013, Israel's health system was ranked
fourth in the world in terms of efficiency.
• In 2011 there were 3.3 practicing physicians per 1000 population in Israel
or 25,300 practicing physicians.
• Almost all employed by the government or HMO – fixed salary!
• Five university medical schools.
• 25 General hospitals with ER [all with CCUs], in 23 cath labs with 24/7
service for Primary PCI.
Health System in Israel
• Medical insurance plan is obligatory.
• All entitled to basic health care as a fundamental right.
• In a survey of 48 countries in 2013, Israel's health system was ranked
fourth in the world in terms of efficiency.
• In 2011 there were 3.3 practicing physicians per 1000 population in Israel
or 25,300 practicing physicians.
• Almost all employed by the government or HMO – fixed salary!
• Five university medical schools.
• 25 General hospitals with ER [all with CCUs], in 23 cath labs with 24/7
service for Primary PCI.
• Most senior physician are also affiliated with one of the 5 universities:
Beer Sheva, Haifa [Technion], Jerusalem, Tel Aviv, Zefat [Bar Ilan].
• No protected time for academy.
Israel: Modelo de innovación biomédica
Ariel Roguin MD PhD
Head, Interventional Cardiology
Rambam Medical Center,
B. Rappaport - Faculty of Medicine
Technion - Israel Institute of Technology
Haifa 31096 ISRAEL
aroguin@technion.ac.il
18
Maimonides / the RAMBAM
Nació en Córdoba (España), 1138 –
Médico, rabino, filósofo y teólogo judío
de al-Ándalus de la Edad Media.
Estatua de Maimónides en Córdoba, España.
Innovations in Israel- patents
Source: USPTO
Innovation climate in Israel
Scientists & Technicians per 10,000 Workers
140
83 80
60
55 55
45 43
33 33 32
25
0
20
40
60
80
100
120
140
Israel US Japan Germany Canada Switzerland Taiwan UK Ireland Italy Singapore Spain
 Julio came to the US to pursue academic career.
 Initial attempts- Make a stent with Radio Shack copper wire
and soldering materials.
 Funds: turned down by a number of companies
 Schatz and Palmaz joined entrepreneur Phillip Romano, who
provided seed money to create a company.
 Up to 1986, Palmaz, Schatz, and Romano were turned down by
virtually everyone.
 Vision and support came eventually through (J&J).
Israel: Modelo de innovación biomédica
 El modelo Israelí,
 Como se trabaja allí
 Como se ha llegado a conseguir ese nivel
de superespecialización en innovación,
 La relación de los médicos con la gestión
de i+I+D [investigacion, desarrollo e
innovacion tecnologica]
DNA for Israel High Tech Success:
Money for start up medical company
 University
 Institution/hospital
 Chief Scientist
 Incubator
 Venture Capital
 Device Company
 Private [your own]
 Angel – private investor
DNA for Israel High Tech Success:
Fudan 201030
30
Haifa
Tel Aviv
Universities in Israel
Beer Sheva
Technion
University of Haifa
Ben Gurion University
Tel Aviv University
Bar Ilan University
Weizmann Institute
Hebrew University
of Jerusalem
Jerusalem
Rehovot
Synergy for Success
Haifa Bay Area
Rambam Medical Center
Technion, Israel Institute of
Technology
University of Haifa
Rappaport Faculty of Medicine
Rappaport Institute for Medical
Research Technion
MATAM High Tech
Synergy for Success
Rambam Medical Center
MATAM High Tech
Technion faculty member
Patent
Company InStent [Private sponsership]
Animal experiments in Technion
Approval for human use
Rambam - Human FIM
Technion faculty member
Patent
Company InStent [Private sponsership]
Animal experiments in Technion
Approval for human use
Rambam - Human FIM
BeStent-
InStent-
Medtronic
Synergy for Success
Haifa Bay Area
Rambam Medical Center
Technion, Israel Institute of
Technology
Rappaport Faculty of Medicine
Rappaport Institute for Medical
Research Technion
MATAM High Tech
 Inspire MD
 Patented
 Private investors
 Venture Capital Investment
 NYSE stock
 Stages in Development
◦ Founded in Haifa(1993)
◦ Idea, technology
development, preclinical
studies, Initial human
studies (1995)
◦ Private investor
◦ Acquired by J&J (1998)
500 million US$
◦ Mapping and ablation
strategies for complex
arrhythmias and AF
Shlomo Ben Haim,
Founder
Electro anatomic Mapping
BioSense- Cordis
Industry with Strong
University Involvement
Trans femoral
Trans
apical
Transcatheter AVR
PVT- Edwards Engineering
by Israeli industry
Clinical studies in France
Sapien AV
Medtronic
CoreValve
TAVI image based analysis:
Perpendicular Projection Selection
 Each point along the curve is perpendicular to the aortic
annulus direction
 Minimizes errors in positioning
+ =
Coronary Application
CRT-D application
Angio-CT Hybrid Imaging
• Founded by the government – chief scientist
• And PHILLIPS
• CT coronary reconstruction
Government
funded
Patented
IP
Angio-CT Hybrid Imaging
prox. LAD
Stenosis due to large plaque with calcified core
Virtual IVUS
feature shows
clearly plaque &
lumen
Short LCx CTO
Synergy for Success
Rambam Medical Center
MATAM High Tech
DNA for Israel High Tech Success:
How is it that Israel:
• a country of 7.1 million people,
• only sixty years old,
• surrounded by enemies,
• in a constant state of war since its founding,
• with no natural resources
produces more start-up companies than large, peaceful, and
stable nations like Japan, China, India, Korea, Canada, and the
United Kingdom?"
DNA for Israel High Tech Success
• Mandatory military service
• Immigration
3 years for Boys
2 years for Girls
Israel Defense Forces
• Leadership and management skills at very early age
• More mature persons
• IDF culture “learn and correct”
• IDF service provides potential entrepreneurs with the opportunities
to develop a wide array of skills and contacts.
Israel Defense Forces
• Leadership and management skills at very early age
• More mature persons
• IDF culture “learn and correct”
• IDF service provides potential entrepreneurs with the opportunities
to develop a wide array of skills and contacts.
• responsibility in a relatively un-hierarchical environment where
creativity and intelligence are highly valued.
• IDF soldiers have minimal guidance from the top, and are expected
to improvise, even if this means breaking some rules.
• If you're a junior officer, you call your higher-ups by their first
names, and if you see them doing something wrong, you say so.
• Neither ranks nor ages matter much "when taxi drivers can
command millionaires and 23-year-olds can train their uncles.
Medicine Studies in Israel
Military Service -> Medicine
Medicine [atuda] -> Doctor in the army for 5
years as officer with multiple responsibilities
Immigration
• 9 out of 10 Jewish Israelis today are immigrants or
descendants of immigrants the first or second generation.
• Since 1990, 1 million immigrants mainly from Soviet union.
• Many hard working engineers.
• In 2014: 1 in 4 academic position speaks Russian.
• This specific demographic, causing fragmentation of
community that still continues in the country, is nevertheless
a great incentive to try their luck, to take risks because
immigrants have nothing to lose.
• Israelis think “out of the box”
Out of the Box thinking
Out of the Box thinking
Paravalvular Leak
“Normal” Country
In Israel
How did Israel become a High tech success?
71
Phases in Israel’s economic development
1948-1968 Agriculture
• Export mainly agriculture
•Building the science based capabilities:
- Technion 1924
- Hebrew University 1925
- Weitzman Institute 1934
•Innovations and entrepreneurship in Agriculture
(Kibbutz) and the Defense area
72
Phases in Israel’s economic development
1969-1992 [Self support market]
• Arms embargo after six day war in 1967
• Army R&D and “atudaim”
• Building defense-industry-university complex
- 65% of R&D defense related
- Defense as % of GDP grew to 25% in 1980
- Indigenous industry for planes, tanks, electronics warfare
• Spin-offs from defense e.g. Elscint, Scitex, Orbitech
• Multinationals entering Israel (e.g. Intel, Motorola)
• Due to historical labor-socialist tradition deep antagonism toward
individual entrepreneurship
• Establishment of Office of Chief Scientist in 1968
73
Phases in Israel’s economic development
1992-2010: take-off high-tech sector
• Yozma, a government initiative in 1993 jump-started VC
availability by leveraging (foreign) risk capital with
government investment fund
• Between 1993-2005 about 80 VC’s raised $ 13,2 bln.
• Numerous government programs to bridge gap between
ideas and first VC investment and to compensate for
market failures
74
Converging factors acting as tipping point for
sustainable hi-tech growth in Israel during the 90’s
VC/PE raised in
Mln dollars
average per year
New High-Tech
Companies
average per year
77From 1969- 1992
1,214307From 1993-2005
Agriculture Nation
Defense and security Nation
High Tech Nation
Tourism Nation
Israel – key phases
?
DNA for Israel High Tech Success:
KEY POINTS
• Established R&D Centers (investigacion, desarrollo)
• Venture Capital
Investments by venture capital funds constitute an added value above financial
contributions - in management, world market familiarity, strategic guidance and
economic credibility.
• Government Support of R&D Expenses
The Chief Scientist of the Ministry of Industry, Trade and Labor offers conditional
R&D grants of up to 50% of approved R&D programs. If successful the developers
are obligated to pay back royalties, up to the amount of the grant.
DNA for Israel High Tech Success
Expenditure on R&D
(as % of GDP,2008)
Source: Ministry of Finance
Unemployment Rate
(harmonized, 2009)
Source: Ministry of Finance
Government Support
• Competitive government assistance for R&D projects
• Tax holidays for up to 10 years for foreign investors
• The reform law for the Encouragement of Capital Investment
will simplify bureaucratic processes related to the approval of
investments through the establishment of a "green lane".
• In addition a "Strategic Track" will offer multinational
companies significant benefits.
Supportive Business Environment
• Worldwide taxation and customs treaties
• Protection of trademarks, patents and intellectual property of
all kinds
• Comprehensive legal protection of foreign companies
Government Reforms
• Liberalization of foreign currency
• Deregulation of foreign trade
• Privatization of government companies
Privatization
• The privatization process began in 1986 and was
accelerated in 1997
• During this time 82 companies have ceased to
be state owned
• 2003:National airline El-Al begins privatization
• From 1986- 2002 $8.6 billion was raised through
privatization
Trade Agreements
• Membership in world organizations: GATT (since 1962), WTO
(since 1995) and an active part in OECD
• Israel has free trade agreements with:
EU (25) EFTA (4) Romania
US Mexico Bulgaria
Canada Turkey
Joint R&D Foundations
• BIRDF – with the U.S.
• USISTC – US-Israel Science and Technology Commission
• BRITECH - with Britain
• CIIRDF – with Canada
• KORIL-RDF – with Korea
• SIIRD – with Singapore
• FRANCE
• GERMANY
• ITALY
• SWEDEN
Government Assistance
Israel - Spain R&D Framework
Israel - Spain R&D Framework
Granting Funding
92
Chief Scientist
Activities in Israel International Activities
R&D Fund Bi-National Funds
Magnet Programs U.S-Israel Science &
Technology Commission
Tnufa BI-National Agreements
Technological Incubators EUREKA
Seed Fund
European Union Programs
Office of the Chief Scientist
Generic R&D
Research Institutes Global Enterprise R&D
Cooperation
Grants: $ 400 mln; Royalty Income: $ 150 mln.
DNA for Israel High Tech Success:
Technological Incubator Projects
23
200
735
54%
technological incubators operate
projects operate currently
projects have left the incubators in the last decade
have received further private investment
Incentives for R&D Centers
National Priority Zone A
National Priority Zone B
Central Israel
Tax relief program: “Cost +”
Three priority areas: A, B, C
Area C
Center of Israel
Area B
preferred regions
of Israel
Area A
most preferred
regions of Israel
2 years - tax
exemption
6 years - tax
exemption
10 years - tax
exemption
8 years – only
10% taxes
4 years – only
10% taxes
Grant Program Priority Zone A Priority Zone B Priority Zone C
Tax Exemption 2 Years Not Applicable Not Applicable
Reduced Company Tax
Israeli Investors 5 Years 7 Years Not Applicable
Foreign Inventors 8 Years 10 Years Not Applicable
Grant Benefit Path
Grant Rates
for Fixed Asset
Priority Zone A Priority Zone B Central Israel
Industrial Projects
(Up to 140M NIS)
24% 10%
Industrial Projects
(Above 140M NIS)
20% 10% Not Applicable
Fixed asset benefit level pending zone
Tax Benefit
Tax Exemption Path
Tax Program Priority Zone A Priority Zone B Priority Zone C
Tax Exemption 10 Years 6 Years 2 Years
Reduced Company Tax
Israeli Investors Not Applicable 1 Year 5 Years
Foreign Inventors Not Applicable 4 Years 8 Years
International Centers for R&D
About 60 foreign R&D centers are located in Israel
AND MORE…
Tax Benefits Table (in %)
Tax Benefit Example
Not an
Approved
Enterprise
Approved Enterprise
Percent of Enterprise owned by Foreign Investors
0-49% 49-74% 74-90% 90-100%
Taxable Income 100 100 100 100 100
Company Tax 34 25 20 15 10%
Balance 66 75 80 85 90
Dividend Tax Percentage 25 25 20 15 10
Dividend Tax 16.5 11.25 12 12.75 13.5
Total Tax on Distributed
income
50.5 36.25 32 27.75 23.5
Fudan 2010100
100
Haifa
Herzliya
Tel Aviv
Jerusalem
Yakum
Multinationals in Israel
Rehovot
Kiryat Gat
Yokneam
Outside of healthcare, multinationals with
significant activity in Israel include:
Over 110 foreign companies have established R&D centers in
Israel, collectively employing over 35,000. Source: Invest in Israel
101
Israel as R&D base
Employment in Foreign R&D Corp.
As a Share of Total Employment in R&D Companies
Source: OECD
4%
3%
5%5%5%
9%9%
6%
5%
19%
17%
15%
20%20%
44%
43%
46%
45%
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
50%
2002 2003 2004 2005 2003 2004 2002 2003 2004 2001 2002 2003 2004 2000 2001 2002 2000 2001
Israel UK Sweden Italy France Finland
102
102
The Israel Case
since the 90’s growth driven by high-tech sector
University of Haifa
Tel-Aviv University
Bar-Ilan University
The Hebrew University of Jerusalem
Ben-Gurion University
Technion
Weizmann Institute of Science
100 km
• 24 incubators
• over 3000 start-ups
• over 80 VC/PE’s
• 63 companies on Nasdaq
• leading multinationals
• matured Israeli high tech
ECO system
Israel (2009)
7.4 Mln inhabitants (in 1948: 0.8 Mln)
GDP $ 204 Bln
GDP per capita
$ 27k
103
The Office of the Chief Scientist Incubator program
• 28 incubators between 1990-1993 (still operating 23)
• Most incubators now privatized
• 1000 companies started in incubator and 45% after a
two years incubator period, attracted follow up financing
• The program has helped to legitimatize tech-
entrepreneurship and lowered entry barriers by
funding and managerial, expert support
Money for start up medical company
 University
 Institution/hospital
 Chief Scientist
 Incubator
 Venture Capital
 Device Company
 Private [your own]
 Angel – private investor
gMPS System
gMPS Sensor
2-D / 3-D “Map” and sensor
position
Low power
magnetic field
The MediGuide gMPS System
Technion Incubator
300 million US$ in 2008
Excellent Human Resources
• Highly educated workforce
• A multilingual population with cultural, historic and business
ties to almost every other nation
• Over 1 million highly educated immigrants from the former
Soviet Union since 1989
• 275 engineers per 10,000 employees
DNA for Israel High Tech Success:
Fudan 2010107
Human Capital -
Israel’s Biggest Asset
Percent with academic degrees (ages 25-64)
Source: the ministry of finance
0
30
60
90
120
150
0%
5%
10%
15%
20%
25%
26% in Science&Engineering
Excellent Human Resources II
• Well established and strong academic infrastructure
• An outstanding entrepreneurial spirit
• Success stories breed success. Everyone wants to be an
ICQ, WAZE or Medinol
• Highly trained graduates of the Israel Defense Forces have
turned cutting edge defense technology into civilian
applications.
Israel leads in encryption software, a by-product
of it’s military industry, as are so many
technologies in which it excels.
“Forbes” June 2002
DNA for Israel High Tech Success:
Modern Infrastructure
• State of the art telecommunications
• World renowned research and educational institutions
• A highly advanced banking and financial sector
• A large volume of high-tech and science based industry
• Early adopters of technology
DNA for Israel High Tech Success:
Fudan 2010110
• Informal, non-hierarchical and collectivism culture conductive to
networking
• Sense of common purpose beyond individual (company) interests
• Network spillovers from army service
• Institutionalized availability of expertise in advisory boards and coaching
• Networked infrastructure of VC,s, Angels, Corp. VC’s, Accountants,
Lawyers, etc.
• Recruitment by referrals and “friend brings friend”
Social Capital
DNA for Israel High Tech Success:
“YES WE CAN”
Israel entrepreneurial culture
“Donttellusitcannotbedone”
DNA for Israel High Tech Success:
112
Entrepreneurship:
The Israeli context and culture
• Informality is a way of life
• Risk taking is endemic
• Three years army service (leadership, teamwork,
technology, risk-taking and improvisation); breeding
ground for entrepreneurs
• Pioneering Ethos and a sense of common purpose
• Immigrants part of the process
• International networks and experience
• Non-hierarchical society
• A real community (high collectivism)
• Building startups has become the national sport;
entrepreneurs-the new cultural heroes (legitimacy)
• Everyone questions authority
DNA for Israel High Tech Success:
DNA for Israel High Tech Success:
Israel High Tech Capital Raised
• Foreign investors have considerably increased their investments in Israeli high-tech and account for a vast majority – 76% -- of capital
investment in Israeli companies.
• The majority of investments over 2013 – two-thirds – was follow-up investment, with first-time investments constituting only one-third
of the total.
• The life-science sector led funding rounds in 2013, attracting 23% of total funds raised, or $522 million. Trailing just behind it was the
software sector, which raised 21% of total capital. Both cyber security and data reached peak investment levels, as did cloud
infrastructure and big data.
IVC Research Center - the leading source of accurate, comprehensive, and
focused information on Israel’s high-tech industry.
Robotic Coronary Cardiac Set-up
Corindus,
Previously Navicath
The Concept of Remote Control Coronary
Interventions
•.
 Bed Side Unit Control unit.
Remote Navigation System for Coronary Catheter based
Interventions
Patented 1998
First 10 patients: The Institute Cardiovascular in Fundeni hospital
Dr. Dan Delano, Bucharest, Romania
Pilot Clinical Trial
Corindus- CorPath 200
• 1998 First Patent filed (today, 19 granted and 38 pending)
• 2002 Company founded (TEIC, Israel)
• 2004 FIM in Romania
• 2006 Corindus Vascular Robotics founded (VC)
• 2010 CorPath 200 FIM results, Corbic Columbia
• 2011 PRECISE trial, 9 centers, 164 pts.
• 2011 Alliance with Phillips
• 2012 July, FDA clearance, Commercial installations
Problems in the High tech Market of Israel
• Looking for “EXITS”.
• Reach a certain level and then sell.
• Good at early stage.
• No large NOKIA etc.
“Rambam Health Care Campus”:
 Rambam Medical Center
 Rappaport School of Medicine
 Rappaport Institute for Research
Technion IIT
University of Haifa
High Tech IndustryEngineers
Physicians
Scientists
Synergy for Success
13
Rambam Campus | 2014
Collaboration and Technology
Transfer
Physician
s
Scientists
Funding
Synergy for Success
Rambam Innovation Fund
Engineers
Physicians
Scientists
Funding
• Each year, 5 innovation grants will
be provided to physicians/
scientists with novel ideas on a
competitive basis
• The grants will fund concept
development, prototype building
and patent protection
• This will form the basis for the next
phase of development
Innovations
Engineering
Science
Medicine
Rambam New Campus - Building the Future
Strategic Plan
Ruth Rappaport Children’s Hospital
Biomedical Discovery Tower
Cardiovascular
Hospital
Joseph
Fishman
Emergency Department
West Campus
Ruth
Rappaport
Children
Hospital
Biomedical
Discovery
Tower
Fishman
Oncology
Center and
the CV
Hospital
Biomedical Discovery
Tower Research and Innovations
Clinical Research Institute
at Rambam (CRIR)
DNA for Israel High Tech Success:
The history of the manuscript began in La Coruña (Corunna), north-western Spain, in 1476 when
Isaac, son of Don Solomon de Braga commissioned a famous scribe, Moses Ibn Zabara to write
the Tenach (Old Testament) together with Rabbi David Kimchi’s (Radak) grammatical treatise
Sefer Mikhlol.
La Coruña Bible
(24th July 1476)
the most lavishly illuminated Hebrew Bible to survive from medieval Spain and
combines Islamic, Christian, and popular motifs
Small country - great spirit!
 Israel has an entrepreneurial spirit
 Israel has the mentality of early adopters
 Israel has a creative fusion between
academy and business
 Israel has a defense technology
commercialization
 Israel has highly skilled workforce
 Israel has a powerful VC community
 Israel has investment and R&D incentives
Israel's technology advantages:
Ventri VCT
GT
Industry based
Clinical Research
Rambam-GE Collaborations in
Imaging
NEOVASC (Banai et al):
CT Angiography of Reducer in CS
Stent Induced coronary
sinus stenosis to enhance
venous perfusion and
collateralization
Israel’s Life Science Industry
Industry Drivers
Technology Transfer Organizations (TTOs)
Commercialized defense technology
Healthcare system
Strong entrepreneurial spirit
Powerful VC community
Highly skilled workforce
Institutional incentives
• Get the right idea
• Secure protection, Secure initial
financing
• Product development
• Preclinical testing
• Clinical Testing
 An enthusiastic and devoted innovator
challenged by obstacles (hospital, university.
private company, other).
 Get the adequate financial
resources to move forward.
 Can proceed in an institutional or
commercial environments.
 It almost always comes with the
requirement to protect the idea
from being copied and duplicated
(patents).
 Get the right team!
 Develop the device towards first-in-man
studies
 Expect a few modification based on
preclinical experience
 Validate the technology with appropriate
in-vitro and animal models before First In
Man.
 Proof of the technology in patients
for a specific indication.
 Phases:
◦ first-in-man
◦ Intermediate size registries
◦ large scale randomized controlled clinical
trials, designed to prove safety and
efficiency.
 This is where ethics and the need to
control conflicts of interest has
becomes a major consideration.
 Compelling clinical need
 Safety and efficacy
 Physician training
 Ease-of-use
 Economic factors (reimbursement)
Commercial
Acceptance
 Encourage industry- academia collaborations
by national programs,
 Mechanisms to promote innovations-
competitive translational grants
 Encourage FIM and innovative clinical studies
in Israel
◦ Shorten and simplify IRB application process
◦ Limit the time to approval
154
Israel- The High-Tech Ecosystem
• Technology Hotbed (20% of Nasdaq companies Israel founded)
– Recognized as an excellent source of technology innovation
– Largest concentration of high-tech companies outside of the US
– Created category leaders in various industries
– Tremendous concentration of global technology leaders
Global
Hi-tech
Companies
Availability of
Technical
People &
Management
Expertise
Existing
Technology
Infrastructure
Experienced
2nd time
entrepreneurs
University
Computer Science
Students
Foreign
Technology
Firms
Incubators
Defense
Corporate
R&D
Leading
Academic
Institutions
& ResearchCorporate
Spin-
Offs
Seasoned VC Community
Government
Support

More Related Content

Similar to Innovations roguin.27112014

Israel
IsraelIsrael
Israel
rothrauff
 
Présentation des biotechnologies en Israël et du secteur médical en Israël
Présentation des biotechnologies en Israël et du secteur médical en IsraëlPrésentation des biotechnologies en Israël et du secteur médical en Israël
Présentation des biotechnologies en Israël et du secteur médical en Israël
FSJU AUJF
 
Israel 2009 Noemi
Israel 2009   NoemiIsrael 2009   Noemi
Israel 2009 Noemi
konzervativci
 
Am israel chai
Am israel chaiAm israel chai
Am israel chai
liat
 
Startup Korea Roundtable 2Q 2015_Israel
Startup Korea Roundtable 2Q 2015_IsraelStartup Korea Roundtable 2Q 2015_Israel
Startup Korea Roundtable 2Q 2015_Israel
D.CAMP
 
First ECTTA Meeting in Budapest. Euromacs Data.
First ECTTA Meeting in Budapest. Euromacs Data.First ECTTA Meeting in Budapest. Euromacs Data.
First ECTTA Meeting in Budapest. Euromacs Data.
Cristiano Amarelli
 
Professionalism in medical_science_-technology_sejojo_mamohato[1]
Professionalism in medical_science_-technology_sejojo_mamohato[1]Professionalism in medical_science_-technology_sejojo_mamohato[1]
Professionalism in medical_science_-technology_sejojo_mamohato[1]
SEJOJO PHAAROE
 
Meeting the-mind-report
Meeting the-mind-reportMeeting the-mind-report
Meeting the-mind-report
Alex Krol
 
Meeting the mind: The Neurotechnology revolution - McKinsey report 2011 Israe...
Meeting the mind: The Neurotechnology revolution - McKinsey report 2011 Israe...Meeting the mind: The Neurotechnology revolution - McKinsey report 2011 Israe...
Meeting the mind: The Neurotechnology revolution - McKinsey report 2011 Israe...
Dmitry Tseitlin
 
Israels' Life Science Industry The Wealth of Innovation
Israels' Life Science IndustryThe Wealth of InnovationIsraels' Life Science IndustryThe Wealth of Innovation
Israels' Life Science Industry The Wealth of Innovation
guestd498e
 
תעשיית מדעי החיים הישראלית – מצגת
תעשיית מדעי החיים הישראלית – מצגתתעשיית מדעי החיים הישראלית – מצגת
תעשיית מדעי החיים הישראלית – מצגת
Israel Export Institute_מכון היצוא
 
Program MedInisrael 2015
Program MedInisrael 2015Program MedInisrael 2015
Program MedInisrael 2015
FSJU AUJF
 
Israel's Startup and VC Ecosystem
Israel's Startup and VC EcosystemIsrael's Startup and VC Ecosystem
Israel's Startup and VC Ecosystem
Pix Vine Capital
 
Investinisrael09 091004045638-phpapp02
Investinisrael09 091004045638-phpapp02Investinisrael09 091004045638-phpapp02
Investinisrael09 091004045638-phpapp02
Stephen Darori
 
Israel Country Risk Analysis
Israel Country Risk Analysis Israel Country Risk Analysis
Israel Country Risk Analysis
Ankush Bagotra
 
Indigenous business sector trade delegation 2018
Indigenous business sector trade delegation 2018Indigenous business sector trade delegation 2018
Indigenous business sector trade delegation 2018
Adam Levin
 
A case study on the Israeli Conceptual Abilities/Innovations by Devsena Mishra
A case study on the Israeli Conceptual Abilities/Innovations by Devsena MishraA case study on the Israeli Conceptual Abilities/Innovations by Devsena Mishra
A case study on the Israeli Conceptual Abilities/Innovations by Devsena Mishra
Devsena Mishra
 
Digital Health Israel Research Paper
Digital Health Israel Research PaperDigital Health Israel Research Paper
Digital Health Israel Research Paper
Koby Sokoloff
 
More than a Hundred Developments, Inventions, and Israeli Successes
More than a Hundred Developments, Inventions, and Israeli Successes More than a Hundred Developments, Inventions, and Israeli Successes
More than a Hundred Developments, Inventions, and Israeli Successes
Galit Zamler
 
Medical genetics in egypt situation and perspectives
Medical genetics in egypt situation and perspectivesMedical genetics in egypt situation and perspectives
Medical genetics in egypt situation and perspectives
Pasteur_Tunis
 

Similar to Innovations roguin.27112014 (20)

Israel
IsraelIsrael
Israel
 
Présentation des biotechnologies en Israël et du secteur médical en Israël
Présentation des biotechnologies en Israël et du secteur médical en IsraëlPrésentation des biotechnologies en Israël et du secteur médical en Israël
Présentation des biotechnologies en Israël et du secteur médical en Israël
 
Israel 2009 Noemi
Israel 2009   NoemiIsrael 2009   Noemi
Israel 2009 Noemi
 
Am israel chai
Am israel chaiAm israel chai
Am israel chai
 
Startup Korea Roundtable 2Q 2015_Israel
Startup Korea Roundtable 2Q 2015_IsraelStartup Korea Roundtable 2Q 2015_Israel
Startup Korea Roundtable 2Q 2015_Israel
 
First ECTTA Meeting in Budapest. Euromacs Data.
First ECTTA Meeting in Budapest. Euromacs Data.First ECTTA Meeting in Budapest. Euromacs Data.
First ECTTA Meeting in Budapest. Euromacs Data.
 
Professionalism in medical_science_-technology_sejojo_mamohato[1]
Professionalism in medical_science_-technology_sejojo_mamohato[1]Professionalism in medical_science_-technology_sejojo_mamohato[1]
Professionalism in medical_science_-technology_sejojo_mamohato[1]
 
Meeting the-mind-report
Meeting the-mind-reportMeeting the-mind-report
Meeting the-mind-report
 
Meeting the mind: The Neurotechnology revolution - McKinsey report 2011 Israe...
Meeting the mind: The Neurotechnology revolution - McKinsey report 2011 Israe...Meeting the mind: The Neurotechnology revolution - McKinsey report 2011 Israe...
Meeting the mind: The Neurotechnology revolution - McKinsey report 2011 Israe...
 
Israels' Life Science Industry The Wealth of Innovation
Israels' Life Science IndustryThe Wealth of InnovationIsraels' Life Science IndustryThe Wealth of Innovation
Israels' Life Science Industry The Wealth of Innovation
 
תעשיית מדעי החיים הישראלית – מצגת
תעשיית מדעי החיים הישראלית – מצגתתעשיית מדעי החיים הישראלית – מצגת
תעשיית מדעי החיים הישראלית – מצגת
 
Program MedInisrael 2015
Program MedInisrael 2015Program MedInisrael 2015
Program MedInisrael 2015
 
Israel's Startup and VC Ecosystem
Israel's Startup and VC EcosystemIsrael's Startup and VC Ecosystem
Israel's Startup and VC Ecosystem
 
Investinisrael09 091004045638-phpapp02
Investinisrael09 091004045638-phpapp02Investinisrael09 091004045638-phpapp02
Investinisrael09 091004045638-phpapp02
 
Israel Country Risk Analysis
Israel Country Risk Analysis Israel Country Risk Analysis
Israel Country Risk Analysis
 
Indigenous business sector trade delegation 2018
Indigenous business sector trade delegation 2018Indigenous business sector trade delegation 2018
Indigenous business sector trade delegation 2018
 
A case study on the Israeli Conceptual Abilities/Innovations by Devsena Mishra
A case study on the Israeli Conceptual Abilities/Innovations by Devsena MishraA case study on the Israeli Conceptual Abilities/Innovations by Devsena Mishra
A case study on the Israeli Conceptual Abilities/Innovations by Devsena Mishra
 
Digital Health Israel Research Paper
Digital Health Israel Research PaperDigital Health Israel Research Paper
Digital Health Israel Research Paper
 
More than a Hundred Developments, Inventions, and Israeli Successes
More than a Hundred Developments, Inventions, and Israeli Successes More than a Hundred Developments, Inventions, and Israeli Successes
More than a Hundred Developments, Inventions, and Israeli Successes
 
Medical genetics in egypt situation and perspectives
Medical genetics in egypt situation and perspectivesMedical genetics in egypt situation and perspectives
Medical genetics in egypt situation and perspectives
 

More from SHCI - Sección de Hemodinámica y Cardiología Intervencionista

Jose maria hernandez intervencionismo en valvulopatia mitral
Jose maria hernandez   intervencionismo en valvulopatia mitralJose maria hernandez   intervencionismo en valvulopatia mitral
Jose maria hernandez intervencionismo en valvulopatia mitral
SHCI - Sección de Hemodinámica y Cardiología Intervencionista
 
Marcel olive perspectivas en la investigacion con productos sanitarios
Marcel olive   perspectivas en la investigacion con productos sanitariosMarcel olive   perspectivas en la investigacion con productos sanitarios
Marcel olive perspectivas en la investigacion con productos sanitarios
SHCI - Sección de Hemodinámica y Cardiología Intervencionista
 
Concepcion rodriguez investigaciones clinicas con productos sanitarios. mar...
Concepcion rodriguez   investigaciones clinicas con productos sanitarios. mar...Concepcion rodriguez   investigaciones clinicas con productos sanitarios. mar...
Concepcion rodriguez investigaciones clinicas con productos sanitarios. mar...
SHCI - Sección de Hemodinámica y Cardiología Intervencionista
 
Jaime elizaga tavi en riesgo bajo
Jaime elizaga   tavi en riesgo bajoJaime elizaga   tavi en riesgo bajo
Borja ibanez perspectiva en investigacion con productos sanitarios
Borja ibanez   perspectiva en investigacion con productos sanitarios Borja ibanez   perspectiva en investigacion con productos sanitarios
Borja ibanez perspectiva en investigacion con productos sanitarios
SHCI - Sección de Hemodinámica y Cardiología Intervencionista
 
Juan granada device development is relative
Juan granada   device development is relativeJuan granada   device development is relative
Juan granada device development is relative
SHCI - Sección de Hemodinámica y Cardiología Intervencionista
 
Pablo avanzas novedades farmacologia en intervencionismo
Pablo avanzas   novedades farmacologia en intervencionismoPablo avanzas   novedades farmacologia en intervencionismo
Pablo avanzas novedades farmacologia en intervencionismo
SHCI - Sección de Hemodinámica y Cardiología Intervencionista
 
Nieves gonzalo novedades en imagen y fisiologia
Nieves gonzalo   novedades en imagen y fisiologiaNieves gonzalo   novedades en imagen y fisiologia
Nieves gonzalo novedades en imagen y fisiologia
SHCI - Sección de Hemodinámica y Cardiología Intervencionista
 
Jose antonio baz novedades en cardiopatia estructural
Jose antonio baz   novedades en cardiopatia estructuralJose antonio baz   novedades en cardiopatia estructural
Jose antonio baz novedades en cardiopatia estructural
SHCI - Sección de Hemodinámica y Cardiología Intervencionista
 
X. quiroga premio
X. quiroga   premioX. quiroga   premio
Victoria vilalta premio
Victoria vilalta   premioVictoria vilalta   premio
Victor jimenez premio mejor articulo
Victor jimenez   premio mejor articuloVictor jimenez   premio mejor articulo
Tomas benito registro watch hd
Tomas benito   registro watch hdTomas benito   registro watch hd
Soledad ojeda novedades intervencionismo coronario
Soledad ojeda   novedades intervencionismo coronarioSoledad ojeda   novedades intervencionismo coronario
Soledad ojeda novedades intervencionismo coronario
SHCI - Sección de Hemodinámica y Cardiología Intervencionista
 
Santiago jimenez valero tavi en riesgo bajo
Santiago jimenez valero   tavi en riesgo bajoSantiago jimenez valero   tavi en riesgo bajo
Santiago jimenez valero tavi en riesgo bajo
SHCI - Sección de Hemodinámica y Cardiología Intervencionista
 
Premio caravel
Premio caravelPremio caravel
Pilar jimenez tavi sin cirugia
Pilar jimenez   tavi sin cirugiaPilar jimenez   tavi sin cirugia
Pilar jimenez registro tavi
Pilar jimenez   registro taviPilar jimenez   registro tavi
Pablo salinas registro de trompa
Pablo salinas   registro de trompaPablo salinas   registro de trompa
Pablo avanzas registro de mitraclip
Pablo avanzas   registro de mitraclipPablo avanzas   registro de mitraclip

More from SHCI - Sección de Hemodinámica y Cardiología Intervencionista (20)

Jose maria hernandez intervencionismo en valvulopatia mitral
Jose maria hernandez   intervencionismo en valvulopatia mitralJose maria hernandez   intervencionismo en valvulopatia mitral
Jose maria hernandez intervencionismo en valvulopatia mitral
 
Marcel olive perspectivas en la investigacion con productos sanitarios
Marcel olive   perspectivas en la investigacion con productos sanitariosMarcel olive   perspectivas en la investigacion con productos sanitarios
Marcel olive perspectivas en la investigacion con productos sanitarios
 
Concepcion rodriguez investigaciones clinicas con productos sanitarios. mar...
Concepcion rodriguez   investigaciones clinicas con productos sanitarios. mar...Concepcion rodriguez   investigaciones clinicas con productos sanitarios. mar...
Concepcion rodriguez investigaciones clinicas con productos sanitarios. mar...
 
Jaime elizaga tavi en riesgo bajo
Jaime elizaga   tavi en riesgo bajoJaime elizaga   tavi en riesgo bajo
Jaime elizaga tavi en riesgo bajo
 
Borja ibanez perspectiva en investigacion con productos sanitarios
Borja ibanez   perspectiva en investigacion con productos sanitarios Borja ibanez   perspectiva en investigacion con productos sanitarios
Borja ibanez perspectiva en investigacion con productos sanitarios
 
Juan granada device development is relative
Juan granada   device development is relativeJuan granada   device development is relative
Juan granada device development is relative
 
Pablo avanzas novedades farmacologia en intervencionismo
Pablo avanzas   novedades farmacologia en intervencionismoPablo avanzas   novedades farmacologia en intervencionismo
Pablo avanzas novedades farmacologia en intervencionismo
 
Nieves gonzalo novedades en imagen y fisiologia
Nieves gonzalo   novedades en imagen y fisiologiaNieves gonzalo   novedades en imagen y fisiologia
Nieves gonzalo novedades en imagen y fisiologia
 
Jose antonio baz novedades en cardiopatia estructural
Jose antonio baz   novedades en cardiopatia estructuralJose antonio baz   novedades en cardiopatia estructural
Jose antonio baz novedades en cardiopatia estructural
 
X. quiroga premio
X. quiroga   premioX. quiroga   premio
X. quiroga premio
 
Victoria vilalta premio
Victoria vilalta   premioVictoria vilalta   premio
Victoria vilalta premio
 
Victor jimenez premio mejor articulo
Victor jimenez   premio mejor articuloVictor jimenez   premio mejor articulo
Victor jimenez premio mejor articulo
 
Tomas benito registro watch hd
Tomas benito   registro watch hdTomas benito   registro watch hd
Tomas benito registro watch hd
 
Soledad ojeda novedades intervencionismo coronario
Soledad ojeda   novedades intervencionismo coronarioSoledad ojeda   novedades intervencionismo coronario
Soledad ojeda novedades intervencionismo coronario
 
Santiago jimenez valero tavi en riesgo bajo
Santiago jimenez valero   tavi en riesgo bajoSantiago jimenez valero   tavi en riesgo bajo
Santiago jimenez valero tavi en riesgo bajo
 
Premio caravel
Premio caravelPremio caravel
Premio caravel
 
Pilar jimenez tavi sin cirugia
Pilar jimenez   tavi sin cirugiaPilar jimenez   tavi sin cirugia
Pilar jimenez tavi sin cirugia
 
Pilar jimenez registro tavi
Pilar jimenez   registro taviPilar jimenez   registro tavi
Pilar jimenez registro tavi
 
Pablo salinas registro de trompa
Pablo salinas   registro de trompaPablo salinas   registro de trompa
Pablo salinas registro de trompa
 
Pablo avanzas registro de mitraclip
Pablo avanzas   registro de mitraclipPablo avanzas   registro de mitraclip
Pablo avanzas registro de mitraclip
 

Innovations roguin.27112014

  • 1. Israel: Modelo de innovación biomédica Ariel Roguin MD PhD Head, Interventional Cardiology Rambam Medical Center, B. Rappaport - Faculty of Medicine Technion - Israel Institute of Technology Haifa 31096 ISRAEL Mobile aroguin@technion.ac.il
  • 3. WAZE navigation Google 2013: 1,200,000 Million US$
  • 4. Israel: Modelo de innovación biomédica  El modelo Israelí,  Como se trabaja allí  Como se ha llegado a conseguir ese nivel de superespecialización en innovación,  La relación de los médicos con la gestión de i+I+D [investigacion, desarrollo e innovacion tecnologica]
  • 5. 5 Israel Facts and Figures Israel HAIFA Established 1948 Area: 22,072 km2 ES:504,645 km2 [X23] Density: 387/km2 ES: 92/km2 [X4] Population ~8 millions ES: ~48 millions [X6] Unemployment: 6% ES: ~25% [X4] GDP per capita 38,000 US$ ES: 33,000 US$ GDP growth 3.3% ES: 2% Natural resources. 0 Security challenges ++++
  • 6. Isolated from its neighbors
  • 9. • No. 1 in patent / capital • 750 life science companies • 7.1 million people = Silicon Valley • 20 x less investment money • Second generation entrepreneurs • Tenacious spirit, focus, and chaos Israel and Innovations in Life Science
  • 10. Major Israeli Medical Innovations  Teva Industry • Copaxon, Azilect  Stents • InStent, BeStent, Nir, Express, InspireMD and more  Biosense • Revolutionized EP  Given Imaging • Revolutionized GI diagnosis  Ventor • Novel Transapical Medtronic Valve Haifa Yokneam
  • 11.
  • 12. Major Israeli Medical Innovations Multislice CT angiographay [Elscint, Picker, Marconi, Philips] MRI imaging [GE R&D] [investigacion, desarrollo] Echocardiography 3D and strain [GE ultasound] Hybrid CT/SPECT [GE Nuclear]
  • 13. Israel: Modelo de innovación biomédica  El modelo Israelí,  Como se trabaja allí  Como se ha llegado a conseguir ese nivel de superespecialización en innovación,  La relación de los médicos con la gestión de i+I+D [investigacion, desarrollo e innovacion tecnologica]
  • 14. Health System in Israel • Medical insurance plan is obligatory. • All entitled to basic health care as a fundamental right. • In a survey of 48 countries in 2013, Israel's health system was ranked fourth in the world in terms of efficiency.
  • 15. Health System in Israel • Medical insurance plan is obligatory. • All entitled to basic health care as a fundamental right. • In a survey of 48 countries in 2013, Israel's health system was ranked fourth in the world in terms of efficiency. • In 2011 there were 3.3 practicing physicians per 1000 population in Israel or 25,300 practicing physicians. • Almost all employed by the government or HMO – fixed salary! • Five university medical schools. • 25 General hospitals with ER [all with CCUs], in 23 cath labs with 24/7 service for Primary PCI.
  • 16. Health System in Israel • Medical insurance plan is obligatory. • All entitled to basic health care as a fundamental right. • In a survey of 48 countries in 2013, Israel's health system was ranked fourth in the world in terms of efficiency. • In 2011 there were 3.3 practicing physicians per 1000 population in Israel or 25,300 practicing physicians. • Almost all employed by the government or HMO – fixed salary! • Five university medical schools. • 25 General hospitals with ER [all with CCUs], in 23 cath labs with 24/7 service for Primary PCI. • Most senior physician are also affiliated with one of the 5 universities: Beer Sheva, Haifa [Technion], Jerusalem, Tel Aviv, Zefat [Bar Ilan]. • No protected time for academy.
  • 17. Israel: Modelo de innovación biomédica Ariel Roguin MD PhD Head, Interventional Cardiology Rambam Medical Center, B. Rappaport - Faculty of Medicine Technion - Israel Institute of Technology Haifa 31096 ISRAEL aroguin@technion.ac.il
  • 18. 18 Maimonides / the RAMBAM Nació en Córdoba (España), 1138 – Médico, rabino, filósofo y teólogo judío de al-Ándalus de la Edad Media. Estatua de Maimónides en Córdoba, España.
  • 19. Innovations in Israel- patents Source: USPTO
  • 20. Innovation climate in Israel Scientists & Technicians per 10,000 Workers 140 83 80 60 55 55 45 43 33 33 32 25 0 20 40 60 80 100 120 140 Israel US Japan Germany Canada Switzerland Taiwan UK Ireland Italy Singapore Spain
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.  Julio came to the US to pursue academic career.  Initial attempts- Make a stent with Radio Shack copper wire and soldering materials.  Funds: turned down by a number of companies  Schatz and Palmaz joined entrepreneur Phillip Romano, who provided seed money to create a company.  Up to 1986, Palmaz, Schatz, and Romano were turned down by virtually everyone.  Vision and support came eventually through (J&J).
  • 26. Israel: Modelo de innovación biomédica  El modelo Israelí,  Como se trabaja allí  Como se ha llegado a conseguir ese nivel de superespecialización en innovación,  La relación de los médicos con la gestión de i+I+D [investigacion, desarrollo e innovacion tecnologica]
  • 27. DNA for Israel High Tech Success:
  • 28. Money for start up medical company  University  Institution/hospital  Chief Scientist  Incubator  Venture Capital  Device Company  Private [your own]  Angel – private investor
  • 29. DNA for Israel High Tech Success:
  • 30. Fudan 201030 30 Haifa Tel Aviv Universities in Israel Beer Sheva Technion University of Haifa Ben Gurion University Tel Aviv University Bar Ilan University Weizmann Institute Hebrew University of Jerusalem Jerusalem Rehovot
  • 31. Synergy for Success Haifa Bay Area Rambam Medical Center Technion, Israel Institute of Technology University of Haifa Rappaport Faculty of Medicine Rappaport Institute for Medical Research Technion MATAM High Tech
  • 32. Synergy for Success Rambam Medical Center MATAM High Tech
  • 33. Technion faculty member Patent Company InStent [Private sponsership] Animal experiments in Technion Approval for human use Rambam - Human FIM
  • 34. Technion faculty member Patent Company InStent [Private sponsership] Animal experiments in Technion Approval for human use Rambam - Human FIM
  • 36. Synergy for Success Haifa Bay Area Rambam Medical Center Technion, Israel Institute of Technology Rappaport Faculty of Medicine Rappaport Institute for Medical Research Technion MATAM High Tech
  • 37.  Inspire MD  Patented  Private investors  Venture Capital Investment  NYSE stock
  • 38.  Stages in Development ◦ Founded in Haifa(1993) ◦ Idea, technology development, preclinical studies, Initial human studies (1995) ◦ Private investor ◦ Acquired by J&J (1998) 500 million US$ ◦ Mapping and ablation strategies for complex arrhythmias and AF Shlomo Ben Haim, Founder
  • 39. Electro anatomic Mapping BioSense- Cordis Industry with Strong University Involvement
  • 40.
  • 41. Trans femoral Trans apical Transcatheter AVR PVT- Edwards Engineering by Israeli industry Clinical studies in France Sapien AV Medtronic CoreValve
  • 42. TAVI image based analysis: Perpendicular Projection Selection  Each point along the curve is perpendicular to the aortic annulus direction  Minimizes errors in positioning + =
  • 44.
  • 45. Angio-CT Hybrid Imaging • Founded by the government – chief scientist • And PHILLIPS • CT coronary reconstruction Government funded Patented IP
  • 47. prox. LAD Stenosis due to large plaque with calcified core Virtual IVUS feature shows clearly plaque & lumen
  • 49. Synergy for Success Rambam Medical Center MATAM High Tech
  • 50. DNA for Israel High Tech Success:
  • 51.
  • 52.
  • 53.
  • 54. How is it that Israel: • a country of 7.1 million people, • only sixty years old, • surrounded by enemies, • in a constant state of war since its founding, • with no natural resources produces more start-up companies than large, peaceful, and stable nations like Japan, China, India, Korea, Canada, and the United Kingdom?"
  • 55. DNA for Israel High Tech Success • Mandatory military service • Immigration
  • 56. 3 years for Boys 2 years for Girls
  • 57.
  • 58.
  • 59. Israel Defense Forces • Leadership and management skills at very early age • More mature persons • IDF culture “learn and correct” • IDF service provides potential entrepreneurs with the opportunities to develop a wide array of skills and contacts.
  • 60. Israel Defense Forces • Leadership and management skills at very early age • More mature persons • IDF culture “learn and correct” • IDF service provides potential entrepreneurs with the opportunities to develop a wide array of skills and contacts. • responsibility in a relatively un-hierarchical environment where creativity and intelligence are highly valued. • IDF soldiers have minimal guidance from the top, and are expected to improvise, even if this means breaking some rules. • If you're a junior officer, you call your higher-ups by their first names, and if you see them doing something wrong, you say so. • Neither ranks nor ages matter much "when taxi drivers can command millionaires and 23-year-olds can train their uncles.
  • 61. Medicine Studies in Israel Military Service -> Medicine Medicine [atuda] -> Doctor in the army for 5 years as officer with multiple responsibilities
  • 62. Immigration • 9 out of 10 Jewish Israelis today are immigrants or descendants of immigrants the first or second generation. • Since 1990, 1 million immigrants mainly from Soviet union. • Many hard working engineers. • In 2014: 1 in 4 academic position speaks Russian. • This specific demographic, causing fragmentation of community that still continues in the country, is nevertheless a great incentive to try their luck, to take risks because immigrants have nothing to lose.
  • 63. • Israelis think “out of the box”
  • 64. Out of the Box thinking
  • 65. Out of the Box thinking
  • 67.
  • 70. How did Israel become a High tech success?
  • 71. 71 Phases in Israel’s economic development 1948-1968 Agriculture • Export mainly agriculture •Building the science based capabilities: - Technion 1924 - Hebrew University 1925 - Weitzman Institute 1934 •Innovations and entrepreneurship in Agriculture (Kibbutz) and the Defense area
  • 72. 72 Phases in Israel’s economic development 1969-1992 [Self support market] • Arms embargo after six day war in 1967 • Army R&D and “atudaim” • Building defense-industry-university complex - 65% of R&D defense related - Defense as % of GDP grew to 25% in 1980 - Indigenous industry for planes, tanks, electronics warfare • Spin-offs from defense e.g. Elscint, Scitex, Orbitech • Multinationals entering Israel (e.g. Intel, Motorola) • Due to historical labor-socialist tradition deep antagonism toward individual entrepreneurship • Establishment of Office of Chief Scientist in 1968
  • 73. 73 Phases in Israel’s economic development 1992-2010: take-off high-tech sector • Yozma, a government initiative in 1993 jump-started VC availability by leveraging (foreign) risk capital with government investment fund • Between 1993-2005 about 80 VC’s raised $ 13,2 bln. • Numerous government programs to bridge gap between ideas and first VC investment and to compensate for market failures
  • 74. 74 Converging factors acting as tipping point for sustainable hi-tech growth in Israel during the 90’s VC/PE raised in Mln dollars average per year New High-Tech Companies average per year 77From 1969- 1992 1,214307From 1993-2005
  • 75. Agriculture Nation Defense and security Nation High Tech Nation Tourism Nation Israel – key phases ?
  • 76. DNA for Israel High Tech Success:
  • 77. KEY POINTS • Established R&D Centers (investigacion, desarrollo) • Venture Capital Investments by venture capital funds constitute an added value above financial contributions - in management, world market familiarity, strategic guidance and economic credibility. • Government Support of R&D Expenses The Chief Scientist of the Ministry of Industry, Trade and Labor offers conditional R&D grants of up to 50% of approved R&D programs. If successful the developers are obligated to pay back royalties, up to the amount of the grant. DNA for Israel High Tech Success
  • 78. Expenditure on R&D (as % of GDP,2008) Source: Ministry of Finance
  • 80. Government Support • Competitive government assistance for R&D projects • Tax holidays for up to 10 years for foreign investors • The reform law for the Encouragement of Capital Investment will simplify bureaucratic processes related to the approval of investments through the establishment of a "green lane". • In addition a "Strategic Track" will offer multinational companies significant benefits.
  • 81. Supportive Business Environment • Worldwide taxation and customs treaties • Protection of trademarks, patents and intellectual property of all kinds • Comprehensive legal protection of foreign companies
  • 82. Government Reforms • Liberalization of foreign currency • Deregulation of foreign trade • Privatization of government companies
  • 83. Privatization • The privatization process began in 1986 and was accelerated in 1997 • During this time 82 companies have ceased to be state owned • 2003:National airline El-Al begins privatization • From 1986- 2002 $8.6 billion was raised through privatization
  • 84. Trade Agreements • Membership in world organizations: GATT (since 1962), WTO (since 1995) and an active part in OECD • Israel has free trade agreements with: EU (25) EFTA (4) Romania US Mexico Bulgaria Canada Turkey
  • 85. Joint R&D Foundations • BIRDF – with the U.S. • USISTC – US-Israel Science and Technology Commission • BRITECH - with Britain • CIIRDF – with Canada • KORIL-RDF – with Korea • SIIRD – with Singapore • FRANCE • GERMANY • ITALY • SWEDEN
  • 87.
  • 88. Israel - Spain R&D Framework
  • 89. Israel - Spain R&D Framework
  • 90.
  • 92. 92 Chief Scientist Activities in Israel International Activities R&D Fund Bi-National Funds Magnet Programs U.S-Israel Science & Technology Commission Tnufa BI-National Agreements Technological Incubators EUREKA Seed Fund European Union Programs Office of the Chief Scientist Generic R&D Research Institutes Global Enterprise R&D Cooperation Grants: $ 400 mln; Royalty Income: $ 150 mln.
  • 93. DNA for Israel High Tech Success:
  • 94. Technological Incubator Projects 23 200 735 54% technological incubators operate projects operate currently projects have left the incubators in the last decade have received further private investment
  • 95. Incentives for R&D Centers National Priority Zone A National Priority Zone B Central Israel Tax relief program: “Cost +” Three priority areas: A, B, C Area C Center of Israel Area B preferred regions of Israel Area A most preferred regions of Israel 2 years - tax exemption 6 years - tax exemption 10 years - tax exemption 8 years – only 10% taxes 4 years – only 10% taxes
  • 96. Grant Program Priority Zone A Priority Zone B Priority Zone C Tax Exemption 2 Years Not Applicable Not Applicable Reduced Company Tax Israeli Investors 5 Years 7 Years Not Applicable Foreign Inventors 8 Years 10 Years Not Applicable Grant Benefit Path Grant Rates for Fixed Asset Priority Zone A Priority Zone B Central Israel Industrial Projects (Up to 140M NIS) 24% 10% Industrial Projects (Above 140M NIS) 20% 10% Not Applicable Fixed asset benefit level pending zone Tax Benefit
  • 97. Tax Exemption Path Tax Program Priority Zone A Priority Zone B Priority Zone C Tax Exemption 10 Years 6 Years 2 Years Reduced Company Tax Israeli Investors Not Applicable 1 Year 5 Years Foreign Inventors Not Applicable 4 Years 8 Years
  • 98. International Centers for R&D About 60 foreign R&D centers are located in Israel AND MORE…
  • 99. Tax Benefits Table (in %) Tax Benefit Example Not an Approved Enterprise Approved Enterprise Percent of Enterprise owned by Foreign Investors 0-49% 49-74% 74-90% 90-100% Taxable Income 100 100 100 100 100 Company Tax 34 25 20 15 10% Balance 66 75 80 85 90 Dividend Tax Percentage 25 25 20 15 10 Dividend Tax 16.5 11.25 12 12.75 13.5 Total Tax on Distributed income 50.5 36.25 32 27.75 23.5
  • 100. Fudan 2010100 100 Haifa Herzliya Tel Aviv Jerusalem Yakum Multinationals in Israel Rehovot Kiryat Gat Yokneam Outside of healthcare, multinationals with significant activity in Israel include: Over 110 foreign companies have established R&D centers in Israel, collectively employing over 35,000. Source: Invest in Israel
  • 101. 101 Israel as R&D base Employment in Foreign R&D Corp. As a Share of Total Employment in R&D Companies Source: OECD 4% 3% 5%5%5% 9%9% 6% 5% 19% 17% 15% 20%20% 44% 43% 46% 45% 0% 5% 10% 15% 20% 25% 30% 35% 40% 45% 50% 2002 2003 2004 2005 2003 2004 2002 2003 2004 2001 2002 2003 2004 2000 2001 2002 2000 2001 Israel UK Sweden Italy France Finland
  • 102. 102 102 The Israel Case since the 90’s growth driven by high-tech sector University of Haifa Tel-Aviv University Bar-Ilan University The Hebrew University of Jerusalem Ben-Gurion University Technion Weizmann Institute of Science 100 km • 24 incubators • over 3000 start-ups • over 80 VC/PE’s • 63 companies on Nasdaq • leading multinationals • matured Israeli high tech ECO system Israel (2009) 7.4 Mln inhabitants (in 1948: 0.8 Mln) GDP $ 204 Bln GDP per capita $ 27k
  • 103. 103 The Office of the Chief Scientist Incubator program • 28 incubators between 1990-1993 (still operating 23) • Most incubators now privatized • 1000 companies started in incubator and 45% after a two years incubator period, attracted follow up financing • The program has helped to legitimatize tech- entrepreneurship and lowered entry barriers by funding and managerial, expert support
  • 104. Money for start up medical company  University  Institution/hospital  Chief Scientist  Incubator  Venture Capital  Device Company  Private [your own]  Angel – private investor
  • 105. gMPS System gMPS Sensor 2-D / 3-D “Map” and sensor position Low power magnetic field The MediGuide gMPS System Technion Incubator 300 million US$ in 2008
  • 106. Excellent Human Resources • Highly educated workforce • A multilingual population with cultural, historic and business ties to almost every other nation • Over 1 million highly educated immigrants from the former Soviet Union since 1989 • 275 engineers per 10,000 employees DNA for Israel High Tech Success:
  • 107. Fudan 2010107 Human Capital - Israel’s Biggest Asset Percent with academic degrees (ages 25-64) Source: the ministry of finance 0 30 60 90 120 150 0% 5% 10% 15% 20% 25% 26% in Science&Engineering
  • 108. Excellent Human Resources II • Well established and strong academic infrastructure • An outstanding entrepreneurial spirit • Success stories breed success. Everyone wants to be an ICQ, WAZE or Medinol • Highly trained graduates of the Israel Defense Forces have turned cutting edge defense technology into civilian applications. Israel leads in encryption software, a by-product of it’s military industry, as are so many technologies in which it excels. “Forbes” June 2002 DNA for Israel High Tech Success:
  • 109. Modern Infrastructure • State of the art telecommunications • World renowned research and educational institutions • A highly advanced banking and financial sector • A large volume of high-tech and science based industry • Early adopters of technology DNA for Israel High Tech Success:
  • 110. Fudan 2010110 • Informal, non-hierarchical and collectivism culture conductive to networking • Sense of common purpose beyond individual (company) interests • Network spillovers from army service • Institutionalized availability of expertise in advisory boards and coaching • Networked infrastructure of VC,s, Angels, Corp. VC’s, Accountants, Lawyers, etc. • Recruitment by referrals and “friend brings friend” Social Capital DNA for Israel High Tech Success:
  • 111. “YES WE CAN” Israel entrepreneurial culture “Donttellusitcannotbedone” DNA for Israel High Tech Success:
  • 112. 112 Entrepreneurship: The Israeli context and culture • Informality is a way of life • Risk taking is endemic • Three years army service (leadership, teamwork, technology, risk-taking and improvisation); breeding ground for entrepreneurs • Pioneering Ethos and a sense of common purpose • Immigrants part of the process • International networks and experience • Non-hierarchical society • A real community (high collectivism) • Building startups has become the national sport; entrepreneurs-the new cultural heroes (legitimacy) • Everyone questions authority DNA for Israel High Tech Success:
  • 113.
  • 114. DNA for Israel High Tech Success:
  • 115. Israel High Tech Capital Raised • Foreign investors have considerably increased their investments in Israeli high-tech and account for a vast majority – 76% -- of capital investment in Israeli companies. • The majority of investments over 2013 – two-thirds – was follow-up investment, with first-time investments constituting only one-third of the total. • The life-science sector led funding rounds in 2013, attracting 23% of total funds raised, or $522 million. Trailing just behind it was the software sector, which raised 21% of total capital. Both cyber security and data reached peak investment levels, as did cloud infrastructure and big data.
  • 116.
  • 117.
  • 118.
  • 119.
  • 120. IVC Research Center - the leading source of accurate, comprehensive, and focused information on Israel’s high-tech industry.
  • 121. Robotic Coronary Cardiac Set-up Corindus, Previously Navicath
  • 122. The Concept of Remote Control Coronary Interventions •.  Bed Side Unit Control unit. Remote Navigation System for Coronary Catheter based Interventions Patented 1998
  • 123. First 10 patients: The Institute Cardiovascular in Fundeni hospital Dr. Dan Delano, Bucharest, Romania Pilot Clinical Trial
  • 124.
  • 126.
  • 127.
  • 128. • 1998 First Patent filed (today, 19 granted and 38 pending) • 2002 Company founded (TEIC, Israel) • 2004 FIM in Romania • 2006 Corindus Vascular Robotics founded (VC) • 2010 CorPath 200 FIM results, Corbic Columbia • 2011 PRECISE trial, 9 centers, 164 pts. • 2011 Alliance with Phillips • 2012 July, FDA clearance, Commercial installations
  • 129. Problems in the High tech Market of Israel • Looking for “EXITS”. • Reach a certain level and then sell. • Good at early stage. • No large NOKIA etc.
  • 130. “Rambam Health Care Campus”:  Rambam Medical Center  Rappaport School of Medicine  Rappaport Institute for Research Technion IIT University of Haifa High Tech IndustryEngineers Physicians Scientists Synergy for Success
  • 133. Rambam Innovation Fund Engineers Physicians Scientists Funding • Each year, 5 innovation grants will be provided to physicians/ scientists with novel ideas on a competitive basis • The grants will fund concept development, prototype building and patent protection • This will form the basis for the next phase of development Innovations Engineering Science Medicine
  • 134. Rambam New Campus - Building the Future Strategic Plan Ruth Rappaport Children’s Hospital Biomedical Discovery Tower Cardiovascular Hospital Joseph Fishman Emergency Department
  • 136. Biomedical Discovery Tower Research and Innovations Clinical Research Institute at Rambam (CRIR)
  • 137. DNA for Israel High Tech Success:
  • 138. The history of the manuscript began in La Coruña (Corunna), north-western Spain, in 1476 when Isaac, son of Don Solomon de Braga commissioned a famous scribe, Moses Ibn Zabara to write the Tenach (Old Testament) together with Rabbi David Kimchi’s (Radak) grammatical treatise Sefer Mikhlol. La Coruña Bible (24th July 1476)
  • 139. the most lavishly illuminated Hebrew Bible to survive from medieval Spain and combines Islamic, Christian, and popular motifs
  • 140. Small country - great spirit!  Israel has an entrepreneurial spirit  Israel has the mentality of early adopters  Israel has a creative fusion between academy and business  Israel has a defense technology commercialization  Israel has highly skilled workforce  Israel has a powerful VC community  Israel has investment and R&D incentives Israel's technology advantages:
  • 143. NEOVASC (Banai et al): CT Angiography of Reducer in CS Stent Induced coronary sinus stenosis to enhance venous perfusion and collateralization
  • 144. Israel’s Life Science Industry Industry Drivers Technology Transfer Organizations (TTOs) Commercialized defense technology Healthcare system Strong entrepreneurial spirit Powerful VC community Highly skilled workforce Institutional incentives
  • 145.
  • 146. • Get the right idea • Secure protection, Secure initial financing • Product development • Preclinical testing • Clinical Testing
  • 147.  An enthusiastic and devoted innovator challenged by obstacles (hospital, university. private company, other).
  • 148.  Get the adequate financial resources to move forward.  Can proceed in an institutional or commercial environments.  It almost always comes with the requirement to protect the idea from being copied and duplicated (patents).
  • 149.  Get the right team!  Develop the device towards first-in-man studies  Expect a few modification based on preclinical experience
  • 150.  Validate the technology with appropriate in-vitro and animal models before First In Man.
  • 151.  Proof of the technology in patients for a specific indication.  Phases: ◦ first-in-man ◦ Intermediate size registries ◦ large scale randomized controlled clinical trials, designed to prove safety and efficiency.  This is where ethics and the need to control conflicts of interest has becomes a major consideration.
  • 152.  Compelling clinical need  Safety and efficacy  Physician training  Ease-of-use  Economic factors (reimbursement) Commercial Acceptance
  • 153.  Encourage industry- academia collaborations by national programs,  Mechanisms to promote innovations- competitive translational grants  Encourage FIM and innovative clinical studies in Israel ◦ Shorten and simplify IRB application process ◦ Limit the time to approval
  • 154. 154 Israel- The High-Tech Ecosystem • Technology Hotbed (20% of Nasdaq companies Israel founded) – Recognized as an excellent source of technology innovation – Largest concentration of high-tech companies outside of the US – Created category leaders in various industries – Tremendous concentration of global technology leaders Global Hi-tech Companies Availability of Technical People & Management Expertise Existing Technology Infrastructure Experienced 2nd time entrepreneurs University Computer Science Students Foreign Technology Firms Incubators Defense Corporate R&D Leading Academic Institutions & ResearchCorporate Spin- Offs Seasoned VC Community Government Support